Find A Physician
Return to New Laser Technology Offers Promise for Heart Disease Patients Overview
More on New Laser Technology Offers Promise for Heart Disease Patients
Hospital News
Return to New Laser Technology Offers Promise for Heart Disease Patients Overview
More on New Laser Technology Offers Promise for Heart Disease Patients
- "Bad" Cholesterol May Not Be the Best Predictor of Heart Disease Risk in Generally Healthy Individuals
- Americans Encouraged to Make Many Lifestyle Changes, Not Just One, to Reduce Cardiovascular Risk
- A NYC First: Patient Participates in Stem Cell Clinical Trial to Repair Heart Damaged by Severe Coronary Artery Disease
- Columbia Research Suggests Need to Rethink Causes of Heart Failure
- Columbia Scientists Study Advantages of Using Web to Tailor Medical Information to Patients
- Columbia University Medical Center Study Shows Stress Test Saves Lives of Patients With Chest Pain
- Dean Antonio M. Gotto, Jr., Elected Fellow of American Academy of Arts and Sciences
- Diabetics Benefit Less from Anti-Hypertensive Treatment to Reduce Enlarged Heart
- Do Heart Disease and Cancer Have a Common Genetic Link?
- For High Blood Pressure Patients, Preventing or Reducing Enlarged Heart May Decrease Risk for Diabetes
- Genetic Medicine Program at Weill Cornell Receives Major Boost from The Starr Foundation
- Health Effects of Secondhand Smoke Studied in First-of-Its-Kind Series of Clinical Studies
- Larger Waistline Is Linked to Increased Risk for Heart Disease in Women
- Lovastatin Treatment Reduces Events in Patients at Varying Degrees of Coronary Risk and Reduces Need for Invasive Procedures
- New Intravascular Radiation Procedures Reduce Renarrowing of Coronary Arteries
- New Methodology Gives Weill Cornell Team Insights into Psychological Value of Cardiac Stress Testing
- NewYork-Presbyterian/Columbia Announces State-of-the-Art, Vivian and Seymour Milstein Family Heart Center in Washington Heights
- NewYork-Presbyterian/Weill Cornell Physician-Scientists Present Findings at American Heart Association's Annual Conference
- NewYork-Presbyterian Hospital and Columbia University Medical Center Physician-Scientists Present Clinical Research at American Heart Association's Annual Conference
- Potential for Adult Stem Cells to Repair Hearts Damaged by Severe Coronary Artery Disease Investigated in Ongoing Study
- Researcher Predicts Paradigm Shift in Heart Disease Treatment
- Research Shows Cholesterol-Lowering Drug Lovastatin Reduces Risk of Heart Attack in Healthy Adults
- Scientific Evidence Points to Male Biological Clock
- Weill Cornell Dean and Cardiovascular Expert Makes "Top Ten" Texas List
- Weill Cornell Researchers Identify a Likely Genetic Cause of Atherosclerosis
Research and Clinical Trials
Return to New Laser Technology Offers Promise for Heart Disease Patients Overview
More on New Laser Technology Offers Promise for Heart Disease Patients
Health Library
Return to New Laser Technology Offers Promise for Heart Disease Patients Overview
More on New Laser Technology Offers Promise for Heart Disease Patients
Clinical Services
Return to New Laser Technology Offers Promise for Heart Disease Patients Overview
More on New Laser Technology Offers Promise for Heart Disease Patients
- Advanced Diagnostics
- Alcohol Septal Ablation
- Angiograms
- Angioplasty and Stenting
- Artificial Heart Devices: LVAD
- Cardiac Electrophysiologic Studies and T-wave Alternans Testing
- Cardiac Magnetic Resonance Imaging (MRI)
- Cardiac Rehabilitation
- Cardiology
- Cardiothoracic Surgery
- Coronary Artery Bypass Surgery (Grafting)
- Echocardiograms
- Electrocardiograms (ECGs), Stress Tests, Holter Monitor and Event/Loop Recorders
- Heart Transplant Surgery
- Intravascular / Intracoronary and Intracardiac Ultrasound
- Nuclear Imaging For Heart Disease (PET scans, MUGA scans)
- Off-pump Surgery
- Pediatric Heart Surgery
- Preventive Cardiology
- Robotic Heart Surgery
- Surgery for Adult Congenital Heart Disease
- Tilt Testing
- Transmyocardial Revascularization
- Treatment of Peripheral Arterial Disease
New Laser Technology Offers Promise for Heart Disease Patients
Cornell University Medical College Tests New TMR System
NEW YORK (Sep 27, 1997)
A new application in transmyocardial revascularization (TMR) laser technology may offer an alternative method of treatment to men and women with severe heart disease who are not candidates for coronary bypass surgery or balloon angioplasty. Cornell University Medical College has received FDA approval to begin a research program to evaluate the Helionetics/Acculase Excimer Laser Transmyocardial Revascularization (TMR) System, a minimally invasive procedure aimed at providing a source of blood flow to areas of ischemic or oxygen-starved heart muscle. Cornell is the only facility on the East Coast participating in this research program.
"Although there have been continued advances in the medical and surgical treatment of coronary heart disease, there exist a significant number of patients for whom cardiac surgery is not indicated because of diffuse atherosclerotic disease (multiple blockages); severe small vessel coronary disease; or multiple reoperations for coronary disease with poor results," said Dr. Todd Rosengart, Assistant Professor, Department of Cardiothoracic Surgery.
"For these patients, many of whom are diabetics, the Excimer Laser may offer a promising alternative."
A normal heart depends primarily on the coronary arteries to deliver its blood supply from the left ventricle cavity, the pumping chamber of the heart. In patients with heart disease, the coronary arteries are blocked preventing normal blood flow to the heart muscle. However, they still have a large supply of oxygenated blood in their left ventricular cavity. For a subset of patients who are not candidates for traditional cardiac surgery, which bypasses blocked arteries, surgeons have to create new pathways for the blood flow.
TMR uses laser energy to create these pathways through a series of 1mm channels from the outer surface of the heart through the heart muscle into the left ventricular cavity, allowing for an increased blood flow directly from this "blood-filled" chamber to the oxygen-starved areas of the heart muscle.
The presently available TMR technology CO2 laser energy must be delivered via a series of mirrors and right angles. "And although studies have found the system to be both safe and effective, it is quite cumbersome and restricting to use," said Dr. Rosengart.
"By transmitting energy through flexible fiberoptics, the Excimer Laser allows surgeons the potential to develop less invasive procedures. This is a significant advantage over the CO2 laser, the current TMR technology," he added.
Other potential advantages of the Excimer Laser include: 1) it lessens thermal effects which results in less scarring and a more favorable healing response; 2) allows for greater potential for long-term channel potency; and 3) reduces risk of air embolism and stroke.
The Cornell research team is led by Dr. Rosengart, O. Wayne Isom, M.D., Chairman, Department of Cardiothoracic Surgery; and Timothy Sanborn, M.D., Chief, Cardiac Catheterization Laboratory. Other surgeons participating in the Cornell program are Karl Krieger, M.D.; Samuel Lang, M.D.; Nasser Altorki, M.D.; Wilson Ko, M.D.; and Charles Mack, M.D.
"TMR is an exciting, new laser treatment for patients with coronary heart disease. The Excimer Laser holds the promise of being the most effective, safest and easiest laser system for doing TMR," said Dr. Sanborn.
Hospital News
- "Bad" Cholesterol May Not Be the Best Predictor of Heart Disease Risk in Generally Healthy Individuals
- Americans Encouraged to Make Many Lifestyle Changes, Not Just One, to Reduce Cardiovascular Risk
- A NYC First: Patient Participates in Stem Cell Clinical Trial to Repair Heart Damaged by Severe Coronary Artery Disease More
